|
Volumn 3, Issue 6, 2005, Pages 1312-
|
Gene therapy for hemophilia?
h
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BLOOD CLOTTING FACTOR 8;
BLOOD CLOTTING FACTOR 9;
CLINICAL RESEARCH;
CYSTIC FIBROSIS;
DRUG DELIVERY SYSTEM;
GENE INSERTION;
GENE THERAPY;
HEMOPHILIA;
LEUKEMIA;
METHODOLOGY;
MUSCULAR DYSTROPHY;
MUTAGENESIS;
NONVIRAL GENE DELIVERY SYSTEM;
PRIORITY JOURNAL;
REVIEW;
STEM CELL TRANSPLANTATION;
TREATMENT OUTCOME;
VASCULAR ACCESS;
ETHICS;
HEMOPHILIA A;
HUMAN;
NOTE;
RISK ASSESSMENT;
GENE THERAPY;
HEMOPHILIA A;
HUMANS;
RISK ASSESSMENT;
|
EID: 24944557267
PISSN: 15387933
EISSN: 15387836
Source Type: Journal
DOI: 10.1111/j.1538-7836.2005.01406.x Document Type: Review |
Times cited : (4)
|
References (0)
|